A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Albemarle Corp stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 40,214 shares of ALB stock, worth $4.41 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
40,214
Previous 42,607 5.62%
Holding current value
$4.41 Million
Previous $4.07 Million 6.41%
% of portfolio
0.01%
Previous 0.02%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$72.85 - $100.09 $174,330 - $239,515
-2,393 Reduced 5.62%
40,214 $3.81 Million
Q2 2024

Jul 26, 2024

SELL
$92.77 - $135.46 $4,360 - $6,366
-47 Reduced 0.11%
42,607 $4.07 Million
Q1 2024

Apr 24, 2024

SELL
$108.73 - $146.89 $776,440 - $1.05 Million
-7,141 Reduced 14.34%
42,654 $5.62 Million
Q4 2023

Feb 09, 2024

SELL
$113.26 - $170.8 $152,787 - $230,409
-1,349 Reduced 2.64%
49,795 $7.19 Million
Q3 2023

Oct 24, 2023

BUY
$162.63 - $243.44 $1.6 Million - $2.39 Million
9,833 Added 23.8%
51,144 $8.7 Million
Q2 2023

Jul 13, 2023

BUY
$172.91 - $232.22 $2.26 Million - $3.04 Million
13,071 Added 46.29%
41,311 $9.22 Million
Q1 2023

May 11, 2023

BUY
$208.49 - $290.15 $978,026 - $1.36 Million
4,691 Added 19.92%
28,240 $6.24 Million
Q4 2022

Feb 08, 2023

BUY
$214.02 - $325.38 $654,259 - $994,686
3,057 Added 14.92%
23,549 $5.11 Million
Q3 2022

Oct 17, 2022

BUY
$195.82 - $307.05 $216,968 - $340,211
1,108 Added 5.72%
20,492 $5.42 Million
Q2 2022

Jul 13, 2022

SELL
$187.76 - $270.92 $324,449 - $468,149
-1,728 Reduced 8.18%
19,384 $4.05 Million
Q1 2022

May 12, 2022

SELL
$172.09 - $246.0 $943,741 - $1.35 Million
-5,484 Reduced 20.62%
21,112 $4.67 Million
Q4 2021

Feb 03, 2022

SELL
$214.16 - $283.8 $1.46 Million - $1.94 Million
-6,830 Reduced 20.43%
26,596 $6.22 Million
Q3 2021

Nov 02, 2021

BUY
$167.91 - $244.03 $1.24 Million - $1.8 Million
7,387 Added 28.37%
33,426 $7.32 Million
Q2 2021

Aug 10, 2021

SELL
$143.7 - $176.01 $243,284 - $297,984
-1,693 Reduced 6.1%
26,039 $4.39 Million
Q1 2021

May 07, 2021

BUY
$140.69 - $185.25 $615,659 - $810,654
4,376 Added 18.74%
27,732 $4.05 Million
Q4 2020

Feb 04, 2021

BUY
$86.73 - $149.91 $645,357 - $1.12 Million
7,441 Added 46.75%
23,356 $3.45 Million
Q3 2020

Oct 29, 2020

BUY
$75.75 - $100.45 $134,532 - $178,399
1,776 Added 12.56%
15,915 $1.42 Million
Q2 2020

Jul 27, 2020

BUY
$52.7 - $86.74 $134,332 - $221,100
2,549 Added 21.99%
14,139 $1.09 Million
Q1 2020

May 08, 2020

BUY
$50.9 - $94.31 $32,168 - $59,603
632 Added 5.77%
11,590 $653,000
Q4 2019

Feb 04, 2020

SELL
$60.74 - $73.04 $58,917 - $70,848
-970 Reduced 8.13%
10,958 $800,000
Q3 2019

Nov 06, 2019

BUY
$59.3 - $75.53 $27,278 - $34,743
460 Added 4.01%
11,928 $829,000
Q3 2019

Oct 28, 2019

SELL
$59.3 - $75.53 $81,418 - $103,702
-1,373 Reduced 10.69%
11,468 $797,000
Q2 2019

Aug 15, 2019

BUY
$63.3 - $86.94 $247,566 - $340,022
3,911 Added 43.8%
12,841 $0
Q1 2019

May 08, 2019

BUY
$72.69 - $92.28 $41,433 - $52,599
570 Added 6.82%
8,930 $0
Q4 2018

Feb 05, 2019

SELL
$73.13 - $107.99 $126,514 - $186,822
-1,730 Reduced 17.15%
8,360 $644,000
Q3 2018

Nov 02, 2018

BUY
$90.9 - $106.6 $230,795 - $270,657
2,539 Added 33.62%
10,090 $0
Q2 2018

Aug 10, 2018

BUY
$88.96 - $104.92 $10,497 - $12,380
118 Added 1.59%
7,551 $0
Q1 2018

May 09, 2018

SELL
$89.56 - $137.45 $146,609 - $225,005
-1,637 Reduced 18.05%
7,433 $0
Q4 2017

Feb 22, 2018

BUY
$127.48 - $144.58 $383,714 - $435,185
3,010 Added 49.67%
9,070 $0
Q3 2017

Nov 07, 2017

BUY
$109.36 - $136.31 $262,464 - $327,144
2,400 Added 65.57%
6,060 $826,000
Q2 2017

Aug 08, 2017

BUY
N/A
3,660
3,660 $386,000

Others Institutions Holding ALB

About ALBEMARLE CORP


  • Ticker ALB
  • Exchange NYSE
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 117,129,000
  • Market Cap $12.8B
  • Description
  • Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...
More about ALB
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.